Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Malefyt RW"'
Autor:
Nicholas B; Division of Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Hampshire, United Kingdom., Lee HH; Oncology & Immunology Discovery, Merck Research Laboratories, Boston, MA, United States., Guo J; Oncology & Immunology Discovery, Merck Research Laboratories, Boston, MA, United States., Cicmil M; Oncology & Immunology Discovery, Merck Research Laboratories, Boston, MA, United States., Blume C; Division of Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Hampshire, United Kingdom., Malefyt RW; Merck Research Laboratories, Palo Alto, CA, United States., Djukanović R; Division of Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Hampshire, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Nov 21; Vol. 13, pp. 973673. Date of Electronic Publication: 2022 Nov 21 (Print Publication: 2022).
Autor:
Perry JA; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Shallberg L; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Clark JT; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Gullicksrud JA; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., DeLong JH; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Douglas BB; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Hart AP; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lanzar Z; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., O'Dea K; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Konradt C; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA.; Purdue University College of Veterinary Medicine, West Lafayette, IN, USA., Park J; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Kuchroo JR; Department of Immunology, Harvard Medical School, Boston, MA, USA., Grubaugh D; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Zaretsky AG; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Brodsky IE; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Malefyt RW; Merck & Co., Kenilworth, NJ, USA., Christian DA; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA., Sharpe AH; Department of Immunology, Harvard Medical School, Boston, MA, USA., Hunter CA; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA, USA. chunter@vet.upenn.edu.
Publikováno v:
Nature immunology [Nat Immunol] 2022 May; Vol. 23 (5), pp. 743-756. Date of Electronic Publication: 2022 Apr 18.
Autor:
Hutchins B; Merck & Co., Inc., Kenilworth, New Jersey. beth.hutchins@merck.com., Starling GC; Merck & Co., Inc., Kenilworth, New Jersey., McCoy MA; Merck & Co., Inc., Kenilworth, New Jersey., Herzyk D; Merck & Co., Inc., Kenilworth, New Jersey., Poulet FM; Merck & Co., Inc., Kenilworth, New Jersey., Dulos J; Merck & Co., Inc., Kenilworth, New Jersey.; Galapagos, Leiden, The Netherlands., Liu L; Merck & Co., Inc., Kenilworth, New Jersey., Kang SP; Merck & Co., Inc., Kenilworth, New Jersey., Fayadat-Dilman L; Merck & Co., Inc., Kenilworth, New Jersey., Hsieh M; Merck & Co., Inc., Kenilworth, New Jersey., Andrews CL; Merck & Co., Inc., Kenilworth, New Jersey., Ayanoglu G; Merck & Co., Inc., Kenilworth, New Jersey., Cullen C; Merck & Co., Inc., Kenilworth, New Jersey.; Apollo Biologics Consulting, Los Angeles, California., Malefyt RW; Merck & Co., Inc., Kenilworth, New Jersey.; Synthekine, Inc., Menlo Park, California., Kastelein RA; Merck & Co., Inc., Kenilworth, New Jersey.; Synthekine, Inc., Menlo Park, California., Saux SL; Merck & Co., Inc., Kenilworth, New Jersey., Lee J; Merck & Co., Inc., Kenilworth, New Jersey., Li S; Merck & Co., Inc., Kenilworth, New Jersey., Malashock D; Merck & Co., Inc., Kenilworth, New Jersey., Sadekova S; Merck & Co., Inc., Kenilworth, New Jersey., Soder G; Merck & Co., Inc., Kenilworth, New Jersey., van Eenennaam H; Merck & Co., Inc., Kenilworth, New Jersey.; AIMM Therapeutics B.V., Amsterdam, The Netherlands., Willingham A; Merck & Co., Inc., Kenilworth, New Jersey., Yu Y; Merck & Co., Inc., Kenilworth, New Jersey., Streuli M; Merck & Co., Inc., Kenilworth, New Jersey.; Pionyr Immunotherapeutics, South San Francisco, California., Carven GJ; Merck & Co., Inc., Kenilworth, New Jersey.; Scholar Rock, Inc., Cambridge, Massachusetts., van Elsas A; Merck & Co., Inc., Kenilworth, New Jersey.; Aduro Biotech, Inc., Berkeley, California.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2020 Jun; Vol. 19 (6), pp. 1298-1307. Date of Electronic Publication: 2020 Mar 30.
Autor:
Bauché D; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., Joyce-Shaikh B; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., Jain R; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., Grein J; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., Ku KS; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., Blumenschein WM; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., Ganal-Vonarburg SC; Maurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Bern, Murtenstrasse 35, 3008 Bern, Switzerland., Wilson DC; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., McClanahan TK; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., Malefyt RW; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., Macpherson AJ; Maurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Bern, Murtenstrasse 35, 3008 Bern, Switzerland., Annamalai L; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., Yearley JH; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA., Cua DJ; Merck & Co., Inc., MRL, Palo Alto, CA 94304-1104 USA. Electronic address: daniel.cua@merck.com.
Publikováno v:
Immunity [Immunity] 2018 Aug 21; Vol. 49 (2), pp. 342-352.e5. Date of Electronic Publication: 2018 Aug 07.
Autor:
Kadowaki N; DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304, USA., Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2001 Sep 17; Vol. 194 (6), pp. 863-9.